Cargando…

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaofan, Zheng, Juan, Zhang, Shixiu, Wang, Baozhen, Wu, Chaodong, Guo, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403443/
https://www.ncbi.nlm.nih.gov/pubmed/32850884
http://dx.doi.org/10.3389/fmed.2020.00361
_version_ 1783566943685443584
author Jiang, Xiaofan
Zheng, Juan
Zhang, Shixiu
Wang, Baozhen
Wu, Chaodong
Guo, Xin
author_facet Jiang, Xiaofan
Zheng, Juan
Zhang, Shixiu
Wang, Baozhen
Wu, Chaodong
Guo, Xin
author_sort Jiang, Xiaofan
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. In particular, microbiota alter intestine absorption of nutrients and intestine permeability, whose dysregulation enhances the delivery of nutrients, endotoxin, and microbiota metabolites to the liver and exacerbates hepatic fat deposition and inflammation. While how altered composition of gut microbiota attributes to NAFLD remains to be elucidated, microbiota metabolites are shown to be involved in the regulation of hepatocyte fat metabolism and liver inflammatory responses. In addition, intestinal microbes and circadian coordinately adjust metabolic regulation in different stages of life. During aging, altered composition of gut microbiota, along with circadian clock dysregulation, appears to contribute to increased incidence and/or severity of NAFLD.
format Online
Article
Text
id pubmed-7403443
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74034432020-08-25 Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD Jiang, Xiaofan Zheng, Juan Zhang, Shixiu Wang, Baozhen Wu, Chaodong Guo, Xin Front Med (Lausanne) Medicine Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. In particular, microbiota alter intestine absorption of nutrients and intestine permeability, whose dysregulation enhances the delivery of nutrients, endotoxin, and microbiota metabolites to the liver and exacerbates hepatic fat deposition and inflammation. While how altered composition of gut microbiota attributes to NAFLD remains to be elucidated, microbiota metabolites are shown to be involved in the regulation of hepatocyte fat metabolism and liver inflammatory responses. In addition, intestinal microbes and circadian coordinately adjust metabolic regulation in different stages of life. During aging, altered composition of gut microbiota, along with circadian clock dysregulation, appears to contribute to increased incidence and/or severity of NAFLD. Frontiers Media S.A. 2020-07-29 /pmc/articles/PMC7403443/ /pubmed/32850884 http://dx.doi.org/10.3389/fmed.2020.00361 Text en Copyright © 2020 Jiang, Zheng, Zhang, Wang, Wu and Guo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jiang, Xiaofan
Zheng, Juan
Zhang, Shixiu
Wang, Baozhen
Wu, Chaodong
Guo, Xin
Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
title Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
title_full Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
title_fullStr Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
title_full_unstemmed Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
title_short Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
title_sort advances in the involvement of gut microbiota in pathophysiology of nafld
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403443/
https://www.ncbi.nlm.nih.gov/pubmed/32850884
http://dx.doi.org/10.3389/fmed.2020.00361
work_keys_str_mv AT jiangxiaofan advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld
AT zhengjuan advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld
AT zhangshixiu advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld
AT wangbaozhen advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld
AT wuchaodong advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld
AT guoxin advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld